Home/Filings/4/0001104659-20-128521
4//SEC Filing

Avista Healthcare Partners GP, Ltd. 4

Accession 0001104659-20-128521

CIK 0001739426other

Filed

Nov 22, 7:00 PM ET

Accepted

Nov 23, 5:10 PM ET

Size

13.3 KB

Accession

0001104659-20-128521

Insider Transaction Report

Form 4
Period: 2020-11-20
Transactions
  • Other

    Ordinary Shares

    2020-11-204,936,9260 total(indirect: By Avista Capital investment fund)
Holdings
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    1,032,995
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    15,730,864
Transactions
  • Other

    Ordinary Shares

    2020-11-204,936,9260 total(indirect: By Avista Capital investment fund)
Holdings
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    15,730,864
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    1,032,995
Transactions
  • Other

    Ordinary Shares

    2020-11-204,936,9260 total(indirect: By Avista Capital investment fund)
Holdings
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    1,032,995
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    15,730,864
Transactions
  • Other

    Ordinary Shares

    2020-11-204,936,9260 total(indirect: By Avista Capital investment fund)
Holdings
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    1,032,995
  • Ordinary Shares

    (indirect: By Avista Capital investment fund)
    15,730,864
Footnotes (3)
  • [F1]Represents shares of the Issuer held by Orbit Co-Invest I LLC. Effective November 20, 2020, Avista Capital Partners III GP, L.P. ("ACP GP") ceased to be the manager of Orbit Co-Invest I LLC and, as a result, ceased to have voting or investment power with respect to the shares held by Orbit Co-Invest I LLC.
  • [F2]Represents shares of the Issuer held by Avista Healthcare Partners, L.P. ("AHP"). Avista Healthcare Partners GP, Ltd. ("AHP GP") is the general partner of AHP. As a result, AHP GP may be deemed to share voting and investment power with respect to the shares held by AHP. Each of AHP and AHP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.
  • [F3]Represents shares of the Issuer held by Orbit Co-Invest III LLC. ACP GP is the manager of Orbit Co-Invest III LLC. As a result, ACP GP may be deemed to share voting and investment power with respect to the shares held by Orbit Co-Invest III LLC. Each of Orbit Co-Invest III LLC and ACP GP disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein, and the inclusion of the shares in this report shall not be deemed to be an admission of beneficial ownership of the reported shares for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise.

Documents

1 file

Issuer

Osmotica Pharmaceuticals plc

CIK 0001739426

Entity typeother
IncorporatedBermuda

Related Parties

1
  • filerCIK 0001799895

Filing Metadata

Form type
4
Filed
Nov 22, 7:00 PM ET
Accepted
Nov 23, 5:10 PM ET
Size
13.3 KB